About |
Metaboliq, Inc. is the company behind GlucoPredict™, an educational platform designed to help people better understand their meals and explore how food choices and portion sizes may influence glucose—Before the First Bite™.
Founded by Anna Laudun Beauboeuf, who has lived with Type 1 diabetes since childhood and brings more than 20 years of healthcare experience, GlucoPredict was inspired by the daily challenges of balancing food, culture, and glucose awareness.
The platform uses AI-assisted meal analysis to provide estimated nutritional information and educational insights. Users can explore meal composition, compare portions, and consider alternatives while keeping familiar foods and cultural traditions part of the conversation.
GlucoPredict is being developed for people living with diabetes or prediabetes, caregivers, and individuals interested in understanding the relationship between food and glucose. Its mission is to make meal information clearer, reduce the mental burden of everyday food decisions, and support meaningful conversations with healthcare professionals.
GlucoPredict provides educational estimates, not measured blood glucose values. It is not intended for diagnosis, treatment, insulin dosing, or clinical decision-making and does not replace professional medical advice.
Learn more at www.glucopredict.com.